Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from

and

Download Data

Arcadia Biosciences Inc Revenue Per Share for the year ending December 31, 2023: USD 4.31

Arcadia Biosciences Inc Revenue Per Share is USD 4.31 for the year ending December 31, 2023, a -74.06% change year over year. Revenue per share measures the amount of revenue generated by a company per outstanding share. It is calculated by dividing the revenue by the number of outstanding shares (weighted average). This ratio provides insights into the company's revenue generation on a per-share basis. A higher revenue per share indicates stronger revenue performance and potentially higher value per share for investors.

Arcadia Biosciences Inc Revenue Per Share for the year ending December 31, 2022 was USD 16.61, a 30.34% change year over year.
Arcadia Biosciences Inc Revenue Per Share for the year ending December 31, 2021 was USD 12.74, a -60.51% change year over year.
Arcadia Biosciences Inc Revenue Per Share for the year ending December 31, 2020 was USD 32.27, a 339.11% change year over year.
Arcadia Biosciences Inc Revenue Per Share for the year ending December 31, 2019 was USD 7.35, a -52.74% change year over year.

NASDAQ: RKDA

Arcadia Biosciences Inc

CEO	Ms. Pamela Haley
IPO Date	May 15, 2015
Location	United States
Headquarters	202 Cousteau Place, Davis, CA, United States, 95618
Employees	21
Sector	Consumer Defensive
Industry	Packaged foods

Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Key trends